Nicholas K. Campbell
No más puestos en curso
Perfil
Nicholas K.
Campbell currently works at Achaogen, Inc., as Chief Restructuring Officer from 2019.
Antiguos cargos conocidos de Nicholas K. Campbell.
| Empresas | Cargo | Fin |
|---|---|---|
| ACHAOGEN | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Nicholas K. Campbell
